Table 3.
Second postoperative stage (epithelial and stromal remodeling).
| Week 1 | Week 2 | Week 3 | Month 1 | Month 2 | ||
|---|---|---|---|---|---|---|
| UCVA (log MAR) | Group A | 0.1 ± 0.19 (−0.1–0.7) | 0.63 ± 0.39 (0–1) | 0.09 ± 0.1 (0–0.3) | 0.07 ± 0.13 (−0.1–0.4) | 0.03 ± 0.08 (−0.1–0.15) |
| Group B | 0.19 ± 0.19 (0–0.7) | 0.32 ± 0.29 (0–0.8) | 0.13 ± 0.11 (0–0.3) | 0.11 ± 0.16 (−0.1–0.4) | 0.02 ± 0.1 (−0.1–0.15) | |
| P value | <0.05∗ | >0.05 | >0.05 | >0.05 | >0.05 | |
|
| ||||||
| Residual cylinder (D) | Group A | 0.42 ± 0.43 (0–1.25) | 0.76 ± 0.54 (0–2.0) | 0.59 ± 0.32 (0.25–1.0) | 0.73 ± 0.5 (0–2.0) | 0.62 ± 0.46 (0–1.5) |
| Group B | 0.7 ± 0.6 (0–1.75) | 0.85 ± 0.77 (0–1.75) | 0.87 ± 0.29 (0.5–1.25) | 0.76 ± 0.52 (0–2.0) | 0.56 ± 0.32 (0.25–1.25) | |
| P value | <0.05∗ | >0.05 | >0.05 | >0.05 | >0.05 | |
|
| ||||||
| Haze (no/epithelial/stromal) (%) | Group A | 37.5/62.5/0 | 30/70/0 | 50/50/0 | 50/28.6/21.4 | 57.1/0/42.9 |
| Group B | 6.3/93.8/0 | 20/80/0 | 50/50/0 | 42.9/21.4/35.7 | 71.4/0/28.6 | |
| P value | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | |
∗Significant.